Business Description
Eli Lilly and Co
NAICS : 325412
SIC : 2834
ISIN : US5324571083
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.17 | |||||
Debt-to-Equity | 2.34 | |||||
Debt-to-EBITDA | 2.94 | |||||
Interest Coverage | 22.68 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 8.94 | |||||
Beneish M-Score | -1.88 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12 | |||||
3-Year EBITDA Growth Rate | -1 | |||||
3-Year EPS without NRI Growth Rate | 0.8 | |||||
3-Year Book Growth Rate | 24.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 50.67 | |||||
Future 3-5Y Total Revenue Growth Rate | 17.33 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 27.06 | |||||
9-Day RSI | 32.25 | |||||
14-Day RSI | 38.41 | |||||
6-1 Month Momentum % | 31.81 | |||||
12-1 Month Momentum % | 100.03 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.94 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.11 | |||||
Days Inventory | 250.76 | |||||
Days Sales Outstanding | 83.85 | |||||
Days Payable | 118.07 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.64 | |||||
Dividend Payout Ratio | 0.51 | |||||
3-Year Dividend Growth Rate | 15.2 | |||||
Forward Dividend Yield % | 0.71 | |||||
5-Year Yield-on-Cost % | 1.29 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 0.12 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 79.25 | |||||
Operating Margin % | 32.29 | |||||
Net Margin % | 15.36 | |||||
FCF Margin % | -9.24 | |||||
ROE % | 47.73 | |||||
ROA % | 9.38 | |||||
ROIC % | 21.84 | |||||
ROC (Joel Greenblatt) % | 61.86 | |||||
ROCE % | 19.77 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 128.62 | |||||
Forward PE Ratio | 58.48 | |||||
PE Ratio without NRI | 82.98 | |||||
Shiller PE Ratio | 144.74 | |||||
PEG Ratio | 7.76 | |||||
PS Ratio | 19.34 | |||||
PB Ratio | 64.46 | |||||
Price-to-Operating-Cash-Flow | 155.47 | |||||
EV-to-EBIT | 101.93 | |||||
EV-to-Forward-EBIT | 53.17 | |||||
EV-to-EBITDA | 83.76 | |||||
EV-to-Forward-EBITDA | 48.47 | |||||
EV-to-Revenue | 21.03 | |||||
EV-to-Forward-Revenue | 17.37 | |||||
EV-to-FCF | -227.67 | |||||
Price-to-Projected-FCF | 12.54 | |||||
Price-to-Median-PS-Value | 3.62 | |||||
Price-to-Peter-Lynch-Fair-Value | 7.75 | |||||
Earnings Yield (Greenblatt) % | 0.98 | |||||
FCF Yield % | -0.45 | |||||
Forward Rate of Return (Yacktman) % | 11.15 |